TTNP - Titan Pharmaceuticals, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue6,61821515,0651,671
Cost of Revenue8,0169,6486,1264,675
Gross Profit-1,398-9,4338,939-3,004
Operating Expenses
Research Development----
Selling General and Administrative6,8665,0694,5963,755
Non Recurring----
Total Operating Expenses14,88214,71710,7228,430
Operating Income or Loss-8,264-14,5024,343-6,759
Income from Continuing Operations
Total Other Income/Expenses Net-759195792-4,520
Earnings Before Interest and Taxes-8,264-14,5024,343-6,759
Interest Expense-887-369-369-369
Income Before Tax-9,023-14,3075,135-11,279
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-9,023-14,3075,135-11,279
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-9,023-14,3075,135-11,279
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-9,308-14,3075,135-11,279